Epic Systems, a major provider of medical records software, has severed its connection with Particle Health, a startup accused of using patient data in unauthorized and unethical ways unrelated to treatment. This action, outlined in a notice to customers, disrupts Particle’s access to over 300 million patient records, as Particle serves as a middleman between… Continue reading Health records giant Epic cracks down on startup for unauthorized sharing of patient data

UnitedHealth Group is set to report its first-quarter earnings, the first major public statement since a cyberattack hit its subsidiary, Change Healthcare, in February. This breach, labeled the largest disruption in U.S. health care since Covid, has brought scrutiny to UnitedHealth’s operations. The incident affected its billing and payment processing service, impacting health-care providers nationwide.… Continue reading UnitedHealth’s first-quarter report will offer a window into Change cyberattack costs

Moderna, a biotech company, has halted its plans to construct a vaccine-manufacturing facility in Kenya due to a significant decrease in demand for its Covid vaccines. Since 2022, the company hasn’t received any vaccine orders from Africa, resulting in over $1 billion in losses and write-downs associated with the cancellation of previous orders from the… Continue reading Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges

Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Corporation”), (TSXV:VPT) announces that it intends to complete, subject to TSXV Venture Exchange (the “Exchange”) acceptance, a non-brokered private placement of up to CDN$3,000,000 (the “Offering”) of unsecured convertible debentures (“Debentures”). Depending on market conditions, the Corporation may increase the size of the Offering, subject to approval of the… Continue reading Ventripoint Announces Non-Brokered Convertible Debenture Private Placement

The Food and Drug Administration (FDA) recently expanded approvals for cell therapies developed by Bristol Myers Squibb and Johnson & Johnson, allowing earlier use in the treatment of multiple myeloma, a type of blood cancer. This decision marks a significant advancement for patients, providing more treatment options and potentially improving outcomes. J&J’s drug, Carvykti, gained… Continue reading Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival

Pfizer announced promising results from a late-stage clinical trial indicating that its vaccine, Abrysvo, exhibits the potential to protect high-risk adults aged 18 to 59 against respiratory syncytial virus (RSV). Currently approved for adults aged 60 and older and expectant mothers, Abrysvo could address a critical gap as there are no RSV shots approved worldwide… Continue reading Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

Google Cloud and Bayer have collaborated to develop an artificial intelligence-powered platform aimed at assisting radiologists in diagnosing patients more efficiently. Thomas Kurian, CEO of Google Cloud, explained that the platform utilizes generative AI to flag anomalies within medical images and retrieve relevant patient information from medical records. This technology streamlines the diagnostic process, enabling… Continue reading Google partners with Bayer on new AI product for radiologists

Former President Donald Trump expressed his stance on abortion laws, advocating for leaving them to the states’ discretion in a video released on his Truth Social media platform. He claimed that abortion had reached a desired legal standpoint post the Supreme Court’s Dobbs decision in 2022, ignoring the majority support for Roe vs. Wade protections… Continue reading Trump says abortion restrictions should be left to states, dodging a national ban

The Denver-Boulder region is rapidly becoming a key hub for the life sciences industry, drawing companies focused on developing cutting-edge medical treatments and technologies. This growth is fueled by a surge in venture capital and government funding, a collaborative research environment, and a booming market for lab space. BioMed Realty, acquired by Blackstone in 2016,… Continue reading Record levels of funding propel Denver-Boulder to the top of the life sciences market

Health insurers in the U.S. experienced a significant decline in their stock prices on Tuesday following the Biden administration’s decision not to increase payments for private Medicare plans as much as anticipated by the insurance industry and investors. CVS Health saw its shares plummet by more than 8%, while UnitedHealth Group witnessed a nearly 7%… Continue reading Health insurer stocks slide as final Medicare Advantage rates disappoint

Prenosis, a health technology company, achieved a significant milestone by obtaining approval from the U.S. Food and Drug Administration (FDA) for its artificial intelligence-powered diagnostic tool for sepsis, marking the first such approval in the field. Sepsis, a life-threatening condition resulting from the body’s extreme response to infection, poses a considerable challenge in diagnosis, with… Continue reading FDA authorizes Prenosis software as first AI tool that can diagnose sepsis

Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company’s clinical study (the “Study”) (NCT05322954) evaluating the safety and feasibility of oral psilocybin as a… Continue reading Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder